Chief Executive Officer

Chief Commercial Officer (CCO)

Priovant’s Brepocitinib Poised to Address Steroid-Sparing Gap in Dermatomyositis as Rheumatologists Anticipate 2026 Launch

Pfizer-backed biotech readies expansion after trial success

Roivant, Priovant plan NDA on positive dermatomyositis data

Roivant, Pfizer’s Therapy Shows ‘Patient-Centered Benefit’ in Rare Inflammatory Condition

Associate General Counsel

Priovant Therapeutics is a biotechnology company dedicated to developing and commercializing novel medicines for rare autoimmune diseases with the highest patient burden. The Associate General Counsel will play a critical role in delivering comprehensive legal support to the Company, providing advice on a broad range of legal, regulatory, and business matters.

Sign up with Google

Sign in with Google